Sernova (TSX: SVA) (OTCQB: SEOVF) is a clinical-stage biotechnology company that is advancing a novel cell therapy platform for the treatment of chronic diseases. Our lead program is evaluating our Cell Pouch System™ as a potential ‘functional cure’ for insulin-dependent diabetes. In addition, we have a robust pipeline that includes preclinical programs in hemophilia A and hypothyroidism. Learn more on our website: https://www.sernova.com/.
Industry
Biotechnology, Scientific Research and Development Services, Services
HQ Location
700 Collip Circle
Suite 114
London, ON N6G 4X8, CA
Keywords
Regenerative MedicineCell Therapyand Biotechnologyregenerative medicinetherapeutic cellanimal modelsinsulin injectionsmedical therapiesmedical technologiestherapeutic technologies